Synergistic activity of GLP-1 peptide analog XW003 and the long-lasting GIP receptor agonist XW017 in a diet induced obese mouse model

被引：0
|
作者：
Wu, Xinle [1 ]
Zou, Haixia [1 ]
Wang, Bin [1 ]
Zhu, Rui [1 ]
Li, Yan [1 ]
Guo, Wanjun [1 ]
Jones, Catherine [1 ]
Fenaux, Martijn [1 ]
机构：
[1] Sciwind Biosci, Hangzhou, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2022年 / 77卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT128
引用
收藏
页码：S726 / S726
页数：1
相关论文
共 13 条
  • [1] Effects of a long-acting secretin peptide analog alone and in combination with a GLP-1R agonist in a diet-induced obesity mouse model
    Loeffler, Mona
    Klepac, Katarina
    Baljuls, Angela
    Hamilton, Bradford
    Mayer-Wrangowski, Svenja
    Haebel, Peter
    Zimmermann, Tina
    MOLECULAR METABOLISM, 2023, 74
  • [2] Semaglutide, a novel long acting GLP-1 receptor agonist, reduced features of NASH in two different diet-induced mouse models
    Norlin, Jenny
    Rakipovski, Gunaj
    Galsgaard, Elisabeth D.
    Henriksson, Emma
    Knudsen, Lotte Bjerre
    HEPATOLOGY, 2017, 66 : 1096A - 1096A
  • [3] ANTI -FIBROTIC EFFECT OF A NOVEL LONG-ACTING GLUCAGON/GIP/GLP-1 TRIPLE AGONIST (HM15211) IN BDL-INDUCED MOUSE MODEL OF LIVER FIBROSIS
    Kim, Jung Kuk
    Jo, Hyo Sang
    Lee, Seon Myeong
    Lee, Jong Suk
    Kwon, Hyunjoo
    Lee, Jong Soo
    Bae, Sung Min
    Lee, Sang Hyun
    Choi, In Young
    HEPATOLOGY, 2020, 72 : 1009 - 1010
  • [4] THERAPEUTIC EFFECT OF A NOVEL LONG-ACTING GLUCAGON/GIP/GLP-1 TRIPLE AGONIST (HM15211) IN CDHFD-INDUCED MOUSE MODEL OF NASH AND FIBROSIS MICE
    Choi, Jaehyuk
    Lee, Seon Myeong
    Kim, Jung Kuk
    Jo, Hyo Sang
    Lee, Jong Suk
    Kwon, Hyunjoo
    Bae, Sung Min
    Kim, Dae Jin
    Lee, Sang Hyun
    Choi, In Young
    HEPATOLOGY, 2020, 72 : 1039 - 1039
  • [5] Role of Renal Sympathetic Nerves in GLP-1 (Glucagon-Like Peptide-1) Receptor Agonist Exendin-4-Mediated Diuresis and Natriuresis in Diet-Induced Obese Rats
    Liu, Xuefei
    Patel, Kaushik P.
    Zheng, Hong
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (21):
  • [6] Improvement of liver fibrosis by a novel long acting Glucagon/GLP-1/GIP triple agonist, efocipegtrutide (HM15211) in carbon tetrachloride-induced mouse model of liver injury and fibrosis
    Lee, Jong Suk
    Kim, Yohan
    Kim, Jung Kuk
    Kwon, Hyunjoo
    Park, Eun Jin
    Kim, Jeong A.
    Park, Sang Hyun
    Bae, Sung Min
    Lee, Sang Hyun
    Choi, In Young
    JOURNAL OF HEPATOLOGY, 2023, 78 : S779 - S780
  • [7] ANTI -INFLAMMATION AND ANTI-FIBROSIS EFFECTS OF A NOVEL LONG-ACTING GLUCAGON/GIP/GLP-1 TRIPLE AGONIST TRIPLE AGONIST (HM15211) IN AMLN/TAA INDUCED MOUSE MODEL OF LIVER INFLAMMATION AND FIBROSIS
    Lee, Jong Suk
    Jo, Hyo Sang
    Kim, Jung Kuk
    Lee, Seon Myeong
    Park, Eun Jin
    Bae, Sung Min
    Kim, Dae Jin
    Kim, Young Hoon
    Choi, In Young
    HEPATOLOGY, 2020, 72 : 1010 - 1011
  • [8] Direct Anti-Inflammatory and Antifibrotic Effects of a Novel Long-Acting Glucagon/GIP/GLP-1 Triple Agonist, HM15211, in Thioacetamide-Induced Mouse Model of Liver Injury and Fibrosis
    Kim, Jung Kuk
    Lee, Jong Suk
    Kim, Yohan
    Lee, Seon Myeong
    Kwon, Hyunjoo
    Park, Eunjin
    Choi, Jaehyuk
    Bae, Sungmin
    Kim, Daejin
    Lee, Sang Hyun
    Choi, In Young
    DIABETES, 2022, 71
  • [9] Anti-inflammatory and anti-fibrotic effects of a novel long-acting Glucagon/GIP/GLP-1 triple agonist, HM15211, in TAA induced mouse model of liver injury and fibrosis
    Kim, J.
    Lee, J.
    Kim, Y.
    Lee, S.
    Kwon, H.
    Park, E.
    Choi, J.
    Bae, S.
    Kim, D.
    Lee, S.
    Choi, I.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S400 - S401
  • [10] EFFECTS OF HM15211, A NOVEL LONG-ACTING GLUCAGON/GIP/GLP-1 TRIPLE AGONIST, ON ANTI-INFLAMMATION AND ANTI-FIBROSIS IN TAA-INDUCED MOUSE MODEL OF LIVER INJURY AND FIBROSIS
    Kwon, Hyunjoo
    Kim, Jung Kuk
    Lee, Jong Suk
    Kim, Yohan
    Park, Eun Jin
    Choi, Jaehyuk
    Bae, Sung Min
    Kim, Dae Jin
    Lee, Sang Hyun
    Choi, In Young
    HEPATOLOGY, 2022, 76 : S716 - S717
12